Abstract
A study of a well-designed androgen-mustard conjugate provides evidence supporting a novel mechanism for its selective toxicity in androgen-receptor- positive cancer cells [1]. This represents a solid step forward on the path toward effective hybrid toxins for targeted cancer therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 719-721 |
Number of pages | 3 |
Journal | Chemistry and Biology |
Volume | 12 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2005 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmacology
- Drug Discovery
- Clinical Biochemistry